WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $26.50 and last traded at $26.0860, with a volume of 1100 shares trading hands. The stock had previously closed at $25.5575.
Wall Street Analyst Weigh In
Separately, Zacks Research upgraded shares of WuXi AppTec from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 7th. One analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. Based on data from MarketBeat.com, WuXi AppTec currently has a consensus rating of “Strong Buy”.
Check Out Our Latest Stock Analysis on WuXi AppTec
WuXi AppTec Stock Performance
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.
Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.
Further Reading
- Five stocks we like better than WuXi AppTec
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
- D-Wave Has Momentum—What Does It Need to Keep It Going?
- TSMC’s Insider Buying Wave Comes With a Bigger AI Question for Investors
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
